New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Wellbeing Matters - new support for practice staff from MIAB (09 Dec 2021)

A recent survey found that 88% of practices said that the pandemic has affected the physical and mental wellbeing of their staff. Whilst the survey cited workload and funding as...
Read more »

Conference of England LMCs 2021 (30 Nov 2021)

The Conference took place on Thursday 25 and Friday 26 November, a list of the motions debated and the parts that were carried is available here. There were a number...
Read more »

Engagement to counter abuse of practice staff (25 Nov 2021)

Our work to raise awareness of the abuse practices are receiving, counter misinformation and seek practical support are continuing. The information provided in response to our recent survey on abuse...
Read more »

New GPC England Chair (25 Nov 2021)

Last week Dr Farah Jameel was elected Chair of the BMA’s General Practitioners Committee England. Farah is a GP in Camden and Joint-Chair of the LMC for the area, she...
Read more »

Supporting patients from migrant communities (25 Nov 2021)

Dr Hannah Theodorou, Londonwide LMCs Medical Director for North West London and Board Member of Doctors of the World writes about GPs’ obligations and best practice when registering and caring...
Read more »

Consultation responses (25 Nov 2021)

In the last month Londonwide LMCs has responded to two Government consultations on behalf of our constituent practices. Data access consultation In November we responded to the “Data A New...
Read more »

Tips of the Month November 2021 (25 Nov 2021)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

Covid-19 guidance update – November 2021 (25 Nov 2021)

This page collates new guidance and existing guidance that has been updated since our last newsletter on 20 October. Covid-19 response guidance Revised UK infection prevention and control...
Read more »
Next Page »
« Previous Page